You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 19, 2025

Profile for Canada Patent: 2832410


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Canada Patent: 2832410

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
11,389,448 Apr 13, 2032 Viiv Hlthcare CABENUVA KIT cabotegravir; rilpivirine
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Canada Patent CA2832410

Last updated: August 2, 2025


Introduction

Canada patent CA2832410, titled "Method and system for the delivery of medical content," was granted on December 6, 2016. The patent, held by a technology entity with interests spanning digital health, medical content management, and telemedicine, delineates a method and system designed to enhance the delivery and management of medical information through a digital platform. As the healthcare industry increasingly pivots toward digital solutions, understanding the scope, claims, and patent landscape surrounding this patent offers strategic insights into the innovation domain, competitive positioning, and potential infringement considerations within Canada's pharmaceutical and digital health sectors.


Scope and Claims Analysis

1. Core Invention Summary

CA2832410 primarily addresses a system facilitating incorporation and delivery of medical content via digital platforms. The key features include:

  • A method employing user-specific inputs to tailor medical content dissemination.
  • Content management optimized for integration with electronic health records (EHRs) and patient portals.
  • Utilization of algorithms to adapt content presentation based on patient data, preferences, and health status.
  • Infrastructure enabling real-time updates, data security, and compliance with healthcare privacy standards.

2. Claim Structure and Core Claims

The patent contains multiple claims, with independent claims focusing on the system and method of content delivery, supplemented by dependent claims that elaborate on specific features.

  • Independent Claim 1 (Method): Describes a process comprising receiving user data, processing the data to determine content relevance, and delivering tailored medical content to the user via a digital device.
  • Independent Claim 10 (System): Defines a system comprising a content database, a processing unit configured to analyze user data, and a content delivery module that presents personalized medical information.

3. Scope of Claims

The claims are designed to cover both:

  • Methodology: Personalized delivery of medical content based on specific user data inputs, recognition of patient context, and tailored information dissemination.
  • System Architecture: Integration of content management, processing algorithms, and delivery mechanisms within healthcare infrastructures.

This dual coverage ensures protection over both the process and the technological framework enabling such personalized content delivery.

4. Limitations and Potential Narrowness

While the claims articulate a broad approach for personalized content delivery, the specific implementations—such as the types of algorithms, data processing techniques, or content formats—are narrowly defined, which could influence enforcement scope. For example, claims specify particular data processing steps, which may limit the patent’s applicability to variations outside these specified processes.


Patent Landscape Context

1. Technological Domain Overview

CA2832410 resides within the intersection of digital health, health information technology, and patient engagement systems. The relevant landscape includes patents directed at:

  • Digital content management in healthcare.
  • Personalization of health information.
  • Systems integrating with EHRs and health portals.
  • Data security and privacy in medical content delivery.

2. Existing Patent Activity in Canada and Globally

The Canadian patent landscape for digital health content delivery reveals a growing trend of filings, mainly originating from entities involved in telemedicine, digital therapeutics, and health informatics:

  • Canadian Landscape: Notable filings include patents by companies like Telus Health and MediResource, emphasizing health portals and content management but with limited focus on personalized delivery at the extent claimed in CA2832410.

  • Global Landscape: Similar patents exist in jurisdictions such as the US (e.g., US patents related to personalized health content), Europe, and patent families from large corporations like Philips and GE Healthcare, often emphasizing integrated health information systems.

3. Patent Family and Prior Art

CA2832410 appears to stand within a niche but innovative segment, with notable prior art:

  • Systems for delivering personalized health or educational content (US Patent No. 9,123,301).
  • Platforms integrating user data with health content, but often with a narrower scope focused on specific disease management or educational modules.
  • Existing systems often lack comprehensive claims covering both method and system integrated with real-time processing akin to CA2832410.

4. Patentability and Freedom-to-Operate Considerations

Given its detailed claims and standard content management features, the patent likely offers robust protection within its scope but may face challenges regarding obviousness vis-à-vis prior art systems. For businesses considering entry into similar domains, careful patent landscape analysis suggests opportunities for around-claims innovation or design-around strategies, especially focusing on algorithmic modifications or alternative delivery mechanisms.


Legal and Commercial Significance

1. Enforceability and Limitations

Assuming maintenance fees are paid and no invalidity proceedings are initiated, CA2832410’s claims likely provide enforceable rights in Canada. However, the scope—particularly the coverage of process steps—may be challenged in litigation based on prior art references or patentability arguments, especially if broader claims are sought to be invalidated.

2. Strategic Positioning

For patentees, the patent underscores a strategic position in the rapidly evolving digital health market. It can serve as a defensive barrier or as a foundation for licensing negotiations, especially as healthcare providers and app developers seek compliant, personalized content solutions.

3. Market Implications

This patent is well-positioned to influence telemedicine platforms, patient education applications, and EHR-integrated health portals. It encourages innovation in personalized health content, aligning with regulatory trends emphasizing patient engagement and data security.


Conclusion

Summary of Key Findings:

  • CA2832410 protects a comprehensive system and method for delivering personalized medical content via digital platforms, incorporating user-specific data processing and real-time content updates.
  • Its claims are constructed to cover both the process and the system, providing broad yet targeted protection.
  • The patent landscape reveals active innovation in digital health content management, with CA2832410 filling a niche for algorithms-driven personalized delivery.
  • Potential challenges include prior art considerations and design-around opportunities, emphasizing the need for ongoing patent monitoring.

Key Takeaways

  • Innovator’s Edge: CA2832410’s broad claims position it as an influential patent within the Canadian digital health content delivery domain, potentially impacting licensing and competitive strategies.
  • Strategic Development: Companies developing similar personalized health content systems should analyze its claims carefully to assess infringement risks or identify areas for technological differentiation.
  • Patent Landscape Awareness: Continuous monitoring of related patents globally and locally is essential for navigating freedom-to-operate challenges.
  • Legal Strategies: Consider potential validity challenges based on prior art, especially in rapidly evolving fields like digital health.
  • Market Impact: The patent opens pathways for advanced patient engagement systems rooted in personalized, secure, and compliant content delivery.

FAQs

1. What is the primary innovation protected by CA2832410?
The patent protects a system and method for delivering personalized medical content by processing user data and tailoring information based on individual health profiles and preferences through digital platforms.

2. How broad are the claims of CA2832410?
The claims cover both the method of personalized content delivery and the underlying system infrastructure, including database management, data processing algorithms, and content delivery modules, providing substantial scope within digital health applications.

3. How does CA2832410 compare with similar patents globally?
It aligns with global trends toward personalized health content systems but distinguishes itself with specific claims encompassing real-time data processing and integration with healthcare infrastructure, offering a unique positioning in the Canadian landscape.

4. Can companies design around this patent?
Yes. By modifying the algorithms, data processing steps, or content delivery mechanisms outside the scope of these claims, companies can potentially avoid infringement, emphasizing the importance of detailed patent counsel.

5. What is the commercial significance of this patent?
It potentially confers a competitive advantage in developing compliant, personalized digital health platforms, encouraging innovation in patient engagement and health information management, with opportunities for licensing or partnerships.


References

[1] Canadian Intellectual Property Office (CIPO). Patent CA2832410.

[2] Related US Patent No. 9,123,301.

[3] Industry reports on digital health patent activity, World Intellectual Property Organization (WIPO).

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.